Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Yang Alex Keun Mo — Polaryx Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Yang Alex Keun Mo

Yang Alex Keun Mo

Director at Polaryx Therapeutics, Inc. · on record since May 28, 2026
Chief Executive Officer at Polaryx Therapeutics, Inc. · on record since May 28, 2026
10% owner at Polaryx Therapeutics, Inc. · on record since May 28, 2026

Insider trading activity of Yang Alex Keun Mo

Transactions on record: 1; since May 28, 2026

Open-market buys: 1; $360K

Open-market sells: 0

Companies traded: 1; last filing May 28, 2026

Figures computed from official regulatory filings — methodology.

Companies where Yang Alex Keun Mo has traded

Polaryx Therapeutics, Inc.1 tx · $360K · May 28, 2026

Track record of Yang Alex Keun Mo

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Yang Alex Keun Mo

Co-insiders of Yang Alex Keun Mo

Berger MitchelPolaryx Therapeutics, Inc.
Bollinger LisaPolaryx Therapeutics, Inc.
Braun III Francis APolaryx Therapeutics, Inc.
Landis G. MichaelPolaryx Therapeutics, Inc.
Mstone Partners Healthcare LtdPolaryx Therapeutics, Inc.
O Andrew JohnPolaryx Therapeutics, Inc.
Ryan Charles S.Polaryx Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Polaryx Therapeutics, Inc.	May 28, 2026	Buy	88,453	4.07 USD	$360K	SEC